Metabolic Brain Disease

, Volume 28, Issue 2, pp 313–320

Disaccharides in the treatment of hepatic encephalopathy

Original Paper

DOI: 10.1007/s11011-013-9392-4

Cite this article as:
Sharma, P. & Sharma, B.C. Metab Brain Dis (2013) 28: 313. doi:10.1007/s11011-013-9392-4


Management of hepatic encephalopathy (HE) primarily involves avoidance of precipitating factors and administration of various ammonia-lowering therapies such as nonabsorbable disaccharides and antimicrobial agents like rifaximin. The nonabsorbable disaccharides which include lactulose and lactitol are considered the first-line therapy for the treatment of HE and minimal hepatic encephalopathy (MHE). Lactulose significantly improves cognitive function and health-related quality of life in patients with MHE. Lactitol is comparable to lactulose in the treatment of HE with fewer side effects. Lactulose has also shown to be effective in primary and secondary prophylaxis of HE. Disaccharides were found to be comparable to rifaximin in recent systemic reviews in the treatment of HE however conclusion was based on inclusion of some poor quality trials. Combination therapy of disaccharides either with rifaximin, L-ornithine L-aspartate,probiotics for the treatment of HE needs further validation in large studies.


Hepatic encephalopathy Disaccharides Lactulose 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of GastroenterologyG.B.Pant HospitalNew DelhiIndia

Personalised recommendations